Nutritional intervention of MAFLD grounded by multiomics profiling
Metabolic-associated fatty liver disease, MAFLD, is the most common cause of liver injury, affecting approximately a quarter of the global population. Despite its prevalence and potential harm to the population and economy, efforts to understand and treat the disease have been fruitless. Its l...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/167699 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Metabolic-associated fatty liver disease, MAFLD, is the most common cause of liver injury,
affecting approximately a quarter of the global population. Despite its prevalence and potential
harm to the population and economy, efforts to understand and treat the disease have been
fruitless. Its long and silent progression makes it extremely difficult to recruit patients to better
understand disease etiology. As such, research efforts must be aided by preclinical models to
provide better insight.
Using a combination of thermoneutral housing and a purified high-fat diet, we
characterized a model that displays the full spectrum of MAFLD with rapid progression to NASH.
These mice showed various metabolic aberrations, such as obesity, metabolic inflexibility,
impaired glucose homeostasis and insulin tolerance.
Transcriptomic analysis of the model also revealed important hallmarks of progression,
which were further supported by histological evidence. Other biochemical analyses, such as
cytokine analysis and lipidomics, also concurred with these results. Importantly, the transcriptomic
signature of our LIDPAD model aligns greatly with that of human NASH patients. This allowed us
to improve MAFLD staging resolution in human NASH patients.
Metagenomic evidence also pointed us towards early gut dysbiosis and liver ROS
elevation, suggesting underlying early events to be the driver of NASH. We also identified a
potential pathway whereby diet could affect gut leakage and disturb gut microbiota. cAngptl4, a
secreted protein associated with tumorigenesis and inflammation, was upregulated in the
intestinal epithelium. Further in vivo experiments suggest that this action is influenced by the fatty
acid-induced PPARα pathway. |
---|